Hero image with Pittsburgh background https://pittplusme.org/study/1250

We're sorry. This study is closed and no longer recruiting participants.

STUDY BASICS

Have you been diagnosed with (or are you suspected of having) Alport syndrome? Are you between the ages of 18-60? If so, you may be able to participate in a research study to find out if a medication called bardoxolone methyl is safe and can help improve the symptoms of Alport Syndrome. Compensation provided.


STUDY PURPOSE
Alport syndrome is a rare genetic condition that leads to problems with the kidneys, eyes, and ears. Symptoms of Alport syndrome can range from mild to severe, and may include blood or protein in the urine, high blood pressure, swelling in the lower limbs, hearing loss, and vision problems. Over time, symptoms become worse and most people develop life-threatening kidney disease. While medications can help slow the progression and relieve some symptoms of Alport syndrome, there is currently no treatment for the underlying disorder. The purpose of this study is to help researchers find out if a medication called bardoxolone methyl is safe and can improve the symptoms of Alport syndrome. While bardoxolone methyl has been tested in over 2,600 patients with diseases including type 2 diabetes, chronic kidney disease, cancer, and pulmonary arterial hypertension, the drug is not currently FDA-approved and is considered to be investigational in this study.
COULD THIS STUDY BE RIGHT FOR YOU?
  • Ages 18-60
  • Diagnosed with Alport syndrome, or suspected of having Alport syndrome
  • Able to swallow capsules
  • Not diagnosed with diabetes

WHAT PARTICIPANTS CAN EXPECT
Participation in this study involves an initial 2-visit screening period to make sure you are eligible for the study. If eligible after screening, you will be randomly assigned (like the flip of a coin) to take a once-daily dose of the study drug or a placebo for 100 weeks. The placebo looks and tastes like the study drug, but does not contain any active medication. During the first year, you will have 10 clinic visits. You will also be called by the study staff. During the second year of the study, you will have 5 study visits. Tests and assessments during the study may include the following: questionnaires, physical exams, pregnancy test, electrocardiogram, vision and hearing tests, blood and urine collection, and genetic testing (if not previously documented).
IRB: 20162760B
- A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Alport Syndrome

PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/1250 and click on "I'm Interested" or call 1-866-438-8230.


LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe

MEET THE RESEARCHER


Christina Nguyen

Christina R. Nguyen, MD, is an Assistant Professor at the University of Pittsburgh School of Medicine. Dr. Nguyen is a graduate of Northeast Ohio Medical University and specializes in Pediatric Nephrology.




MEET THE COORDINATOR


Kathryn Little

Kathryn (KC) Little, RN, is a clinical research nurse coordinator with experience conducting clinical trials.